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The massive infiltration of lymphocytes into the skin is a hallmark of numerous human
skin disorders. By co-culturing murine keratinocytes with splenic T cells we demonstrate
here that T cells affect and control the synthesis and secretion of chemokines by
keratinocytes. While pre-activated CD8+T cells induce the synthesis of CXCL9 and
CXCL10 in keratinocytes and keep in check the synthesis of CXCL1, CXCL5, and CCL20,
keratinocytes dampen the synthesis of CCL3 and CCL4 in pre-activated CD8+T cells.
One keymolecule is IFN-γ that is synthesized by CD8+T cells under the control of NFATc1
and NFATc2. CD8+T cells deficient for both NFAT factors are unable to induce CXCL9
and CXCL10 expression. In addition, CD8+T cells induced numerous type I IFN-inducible
“defense genes” in keratinocytes encoding the PD1 and CD40 ligands, TNF-α and
caspase-1. The enhanced expression of type I IFN-inducible genes resembles the gene
expression pattern at the dermal/epidermal interface in lichen planus, an inflammatory
T lymphocyte-driven skin disease, in which we detected the expression of CXCL10 in
keratinocytes in close vicinity to the infiltration front of T cells. These data reflect the
multifaceted interplay of lymphocytes with keratinocytes at the molecular level.
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INTRODUCTION
Interactions between keratinocytes and leukocytes play a decisive role in the development of
numerous skin diseases. Chemotactic chemokines attract leukocytes to the skin and direct them
to the sites of inflammation, infections, and wounds (1, 2). Keratinocytes synthesize a restricted
set of chemokines whose synthesis is amplified by numerous stimuli, including type I IFNs, IFN-γ,
TNF-α, and others that, to a large part, are produced by lymphocytes and other cells. In addition, the
infiltration of lymphocytes into the skin induces a pattern of chemokines that are either synthesized
at very low amounts or not at all by keratinocytes under homeostatic conditions (3). Although there
have been numerous attempts to elucidate the role of individual chemokines in the generation of
skin diseases, our current knowledge on the interplay of the immune system with the skin and the
function of the chemokine network in skin physiology and pathology is far from clear.
There are∼50 chemokines and 20 chemokine receptors (4) that, in addition to control leukocyte
traffic (5), play an important role in the differentiation and function of lymphocytes during immune
reactions. Both in bone marrow and thymus the development of lymphoid cells is guided by
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the interaction of chemokines with their receptors (6, 7). In
periphery, due to the expression of chemokine receptor CCR7,
memory T cells have been classified into CCR7+ central memory
TCM cells that are enriched in lymph nodes and tonsils, and
CCR7− effector memory TEM cells that are enriched in non-
lymphoid organs (8). Several chemokine receptors including
CCR4, CCR8, and CCR10 have been described to direct T
cells to the inflamed skin and orchestrate T cell-keratinocyte
interactions (9, 10).
The differentiation of keratinocytes in the epidermis, the
first barrier of the organism against the environment, is a fine-
tuned process that is disturbed under pathological conditions.
Keratinocytes of the stratum basale proliferate, detach and
migrate to the stratum spinosum and stratum granulosum and
finally differentiate to corneocytes of the stratum corneum. Under
physiological conditions this process takes 1 week in mice and 4
weeks in humans (11). The cells of the stratum basale are in close
contact with the basement membrane and the dermis in which
the majority of skin lymphocytes patrol. In skin disorders there is
often a massive infiltration of lymphocytes into the dermis and,
less frequently, into the epidermis. Infiltrating lymphocytes affect
the proliferation of keratinocytes and disturb their differentiation
to corneocytes. Lichenoid dermatoses such as cutaneous lupus
erythematosus and lichen planus (12) are prototypic skin
disorders that are characterized by a massive infiltration of
cytotoxic lymphocytes and the “liquefaction degeneration” of
the basal layer of the epidermis. Those infiltrating lymphocytes
show a high expression of the chemokine receptor CXCR3,
the common receptor of the chemokines CXCL9, CXCL10, and
CXCL11. Due to their massive IFN-γ production, infiltrating T
cells induce the synthesis of CXCL9 and CXCL10 in keratinocytes
that, on the other hand, perpetuate and accelerate the further
infiltration of activated T cells to the skin (13–15).
To elucidate the molecular events that orchestrate the
interplay between keratinocytes and skin-infiltrating CD8+T
cells we co-cultivated both types of cells and determined their
chemokine profile. While similar to other authors (3) we detected
a strong induction of the chemokines CXCL9 and CXCL10 in
keratinocytes by IFN-γ, we observed that CCL3 and CCL4, which
are expressed by cytotoxic T cells under the control of NFAT
factors, are inhibited. On the other hand, CXCL1, CXCL5, and
CCL20 expressed by keratinocytes are kept in check by T cell-
derived IFN-γ. The massive induction of CXCL9 and CXCL10 is
linked to the expression of NFATc1 and NFATc2 since CD8+T
cells deficient for these NFATs were unable to stimulate both
chemokines. In lichen planus patients who show a massive T cell
infiltration into the skin we detected the expression of CXCL10 in
keratinocytes near the invasion front. In addition to chemokines,
the co-culture of CD8+T cells with keratinocytes resulted in
the expression of a number of type I IFN-inducible “survival
molecules” by keratinocytes such as the PD1 and CD40 ligands,
TNF-α and caspase 1 that affect the fate of keratinocytes.
Abbreviations: CsA, cyclosporine A; CTL, cytotoxic T cells; DKO T cells, T cells
deficient for NFATc1 and NFATc2; Interferon-γ, IFN-γ; LP, lichen planus; NGS,
next generation sequencing; TNF-α, Tumor necrosis factor α; T+I, TPA and
ionomycin; IFN, Type I interferon.
MATERIALS AND METHODS
Mice, Isolation and Culture of Cells
Eight to twelve weeks old C57/B6, sex-, and age-matched mice
were used in the experiments. Transgenic mice expressing
NFATc1-bio protein as well as the Nfatc1flx/flx x Cd4-cre and
Nfatc2−/− mouse lines have been described previously (16).
NFAT DKO mice were generated by crossing of Nfatc1flx/flx
x Cd4-cre and Nfatc2−/− mice. Primary murine keratinocytes
were either isolated from tails of adult mice or from newborn
mice according to Lichti et al. (17) with slight modifications.
Both mouse tails and newborn mice were disinfected using 7.5%
povidone-iodine solution followed by extensive washes in 70%
ethanol and distilled water. Upon preparation of skin, skin pieces
were incubated overnight in dispase solution at 4◦C followed by
a short digestion in trypsin and incubation for 6 h in S-MEM
(Gibco) medium containing 1.3mM Ca++. After 6 h, cells were
replenished with keratinocyte SFMmedium containing 0.06mM
Ca++ (Gibco) for further culture. Since porcine trypsin kills
murine keratinocytes, all cell culture divisions were performed
with TrypsinLE (Gibco; # 12605-010). Keratinocyte cultures
were treated with murine IL-1α (Preprotech 211-11A; 30 ng/ml),
murine TNF-α (Preprotech 315-01A; 30 ng/ml), or murine IL-
25 (Biolegend 587302; 2µg/ml) for 1 and 3 d. To some cultures,
neutralizing Abs directed against IFN-γ (Biolegend 505702;
5µg/ml) or 100 ng/ml CsA were added.
All co-cultures of keratinocytes with CD8+T cells were
performed at least 3 times in duplicate. Splenic T cells were
isolated using mouse CD8 microbeads kit (Miltenyi Biotech,
#130-049-401) according to the manufacturer’s instructions and
cultured in X-VIVOTM 15 medium (Lonza, BE02-060F). Cells
were pre-activated by αCD3/CD28 (5 µg CD3ε, clone 73.51, BD
Pharmingen) and CD28 (2 µg, clone 145-2C1, BD Pharmingen),
diluted in 1ml PBS for coating. The same number or 2-fold more
pre-activated T cells were co-cultured for 1 or 3 d with freshly
prepared keratinocytes. Due to the strong differentiation effect of
Ca++-containing X-VIVOmedium on primary keratinocytes, all
co-cultures contained 4 parts SFM and 1 part X-VIVO medium.
Transcriptome Analysis by Next Generation
Sequencing (NGS)
Keratinocytes, either cultured alone, or after co-culture with
CD8+ T cells, were deep-frozen in liquid nitrogen. Their RNA
was extracted using Qiagen’s RNeasy plus mini kit. The quantity
of RNA was assessed using a Qubit 2.0 fluorometer, the quality of
RNA was determined on a Bioanalyzer 2100 using a RNA 6000
nano chip. RNA-Seq libraries for NGS were prepared using 20
ng total RNA (RIN>8) and the NEBnext ultra II RNA Library
Prep kit following the manufacturer’s instructions. Barcoded
RNA-Seq libraries were onboard clustered using HiSeq Rapid
SR Cluster Kit v2 using 8 p. m. and 59 bps were sequenced
on an Illumina HiSeq2500 using a HiSeq Rapid SBS kit v2.
Sequencing raw data were further processed using the software
CLC Genomics workbench (v7.5.1 with CLC’s default settings
for RNA-Seq analysis). Reads were aligned to the GRCm38
genome. For the pathway enrichment analysis (shown in Table 1
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TABLE 1 | Compilation of the first top 10 pathways that were changed in murine keratinocytes upon co-culture with pre-activated CD8+ T cells for 1 d.
GO term Description P-value FOR g-value Enrichment (N, B, n, b)
G0:0035456 Response to interferon-beta 1.05E-28 1.35E-24 47.44 (8048,39,87,20)
G0:0035458 Cellular response to interferon-beta 2.46E-28 1.59E-24 62.01 (8048,32,73,18)
G0:0051707 Response to other organism 1.55E-25 6.64E-22 8.37 (8048,271,149,42)
G0:0043207 Response to external biotic stimulus 3.63E-23 1.17E-19 6.68 (8048,364,149,45)
G0:0006952 Defense response 6.54E-23 1.68E-19 8.33 (8048,411,87,37)
G0:0009607 Response to biotic stimulus 2.70E-22 5.79E-19 6.38 (8048,381,149,45)
G0:0009617 Response to bacterium 1.19E-20 2.19E-17 4.82 (8048,141,604,51)
G0:0002376 Immune system process 1.28E-20 2.06E-17 4.45 (8048,703,144,56)
G0:0006955 Immune response 7.31E-19 1.05E-15 5.98 (8048,345,160,41)
G0:0051704 Multi-organism process 2.85E-18 3.67E-15 6.21 (8048,436,113,38)
RNAs of keratinocytes were isolated and their transcriptome determined in NGS assays. Five hundred three genes whose expression was changed 2.5 fold between keratinocytes
co-cultured with CD8+ T cells compared with keratinocytes alone were classified using the Gorilla (Gene Ontology enRIchment anaLysis and visualization) tool (18). GO, gene ontology
terms. FDR (False Discovery Rate) q-value is the correction of the indicated p-value for multiple testing using the Benjamini and Hochberg method. The enrichment (N,B, n,b) is defined
as follows: N is the total number of genes, B is the total number of genes associated with a specific GO term, n is the number of genes in the top of the user’s input list (or in the target
set when appropriate), b is the number of genes in the intersection. Enrichment = (b/n)/(B/N). The individual genes in the 10 intersections are presented in Supplementary Table 1.
and Supplementary Table 1) the GORILLA (gene ontology
enrichment analysis and visualization) tool was used (18).
The data of NGS assays have been deposited in the GEO
database (GSE131905).
Immunohistochemistry
All specimens were obtained from the archive of paraffin-
embedded diagnostic tissues of the Department of Dermatology
at the University Hospital of Würzburg, Germany, and were used
in accordance to the guidelines of the local ethics committee.
Anonymized sections were prepared from formalin-fixed,
paraffin-embedded skin biopsies from lichen planus patients.
Immunohistochemical stains were performed using mAb specific
for CD8 (clone SP-16, dilution 1:50, Invitrogen), NFATc1 (clone
7A6, dilution 1:100, BD Pharmingen), NFATc2 (clone D43B1,
dilution 1:200, Cell signaling), CXCL9 (MIG, dilution 1:15, R&D
systems), or CXCL10 (Polyclonal, clone 33036, Dilution 1:15,
R&D Systems) following the manufacturer’s instructions. The
stained slides were captured with confocal microscope (Zeiss)
or a Nikon Ti motorized stage fluorescence microscope at the
magnifications indicated. The absolute numbers of keratinocytes
expressing CXCL10 were determined using ImageJ.
Enzyme-Linked Immunosorbent Assay
(ELISA)
The concentration of IFN-γ in the culture supernatants was
determined using commercially available mouse IFN-γ ELISA
kits (88-7314-88, Invitrogen). Each sample was analyzed in
duplicate following the manufacturer’s instructions.
Chemokine Secretion Assay
For chemokine measurements, we used the LEGENDplexTM
Mouse Proinflammatory Chemokine Panel (BioLegend)
kit according to the manufacturer’s instructions. This is a
multiple fluorescence-encoded bead-based assay allowing
the simultaneous detection of 13 different chemokines by
flow cytometry.
Statistical Analysis
Statistical analyses were performed using GraphPad (Prism)
software, version 6.0. Data were presented as mean ± SEM.
Unpaired t-test was performed to evaluate the statistical
significance. Statistical significances are indicated (∗∗∗p < 0.001,
∗∗p< 0.005, and ∗p< 0.05).
RESULTS
Secretion of Chemokines by Primary
Murine Keratinocytes ex vivo
To determine the effect of lymphocytes on the secretion of
chemokines by keratinocytes, we isolated primary keratinocytes
from the tails of adult mice, and from newborn mice
and cultured them in serum-free SFM keratinocyte medium
(Gibco) supplemented with 0.06mM Ca++. Under these
conditions, which resemble those of the stratum basale,
the keratinocytes rapidly formed a lawn of cobblestone-
like cells. However, upon co-culture with splenic CD8+ or
CD4+ T cells activated by αCD3/CD28 Abs for 1 d (or
upon stimulation of keratinocytes with IL-1α, TNF-α, or IL-
25) the tight layer of keratinocytes showed numerous holes
in which T cells assembled (Supplementary Figures 1A–C).
After 1 day of co-culture, no measurable differences were
observed in cell viability and cell proliferation, as compared
to individual cell cultures (Supplementary Figure 1D and
data not shown). After one and 3 days of co-culture,
the supernatant of cultures was collected to determine the
secretion of 13 chemokines using a fluorescence-encoded bead-
based assay (BioLegend). In addition, transcriptional changes
of keratinocytes induced in the co-cultures were measured
in NGS assays. Keratinocytes from adult or newborn mice
cultured in vitro for 1 or 3 d secrete a restricted set of
chemokines, mainly CXCL1 and CCL2, and very low amounts
of CXCL5 (Figure 1, lanes 1, 9, and Supplementary Figure 2).
Stimulation of adult keratinocytes with IL-1α and TNF-
α enhanced CXCL1 and CCL2 secretion. Co-cultures of
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keratinocytes with pre-activated T cells resulted in an increase
of CXCL5 secretion and also in the appearance of newly
induced chemokines such as CCL3, CCL4, CXCL9 and
CXCL10 (Figure 1, lanes 5-6 and 13-14), which remained
unaffected by adding CsA to the co-cultures (Figure 1,
lanes 8/16).
The pattern of chemokines secreted by keratinocytes
from the skin of newborn mice overlapped with that of
adult tail keratinocytes but differed in detail. Remarkably,
the stimuli that enhanced chemokine production diverged
conspicuously between both types of keratinocytes. While
IL-1α, TNF-α, and IL-25 affected mildly—or not at all—
the chemokine production of adult tail keratinocytes,
these stimuli strongly affected the secretion of CXCL5
and CCL20 by keratinocytes from newborn mice.
Adding IL-1α and TNF-α to keratinocytes from newborn
mice resulted in a 100 fold increase of CXCL5 and
somewhat weaker of CCL20 secretion upon culture for 3 d
(Supplementary Figure 2).
CD8+T Cells Control Chemokine Secretion
of Keratinocytes
In the co-cultures of T cells with keratinocytes, the same
number (ratio 1:1) or 2-fold more CD8+T cells (i.e., ratio 2:1)
pre-activated for 1 d by αCD3/CD28 Abs in X-vivo-medium
were added. Since keratinocytes were maintained in serum-free
keratinocyte medium this resulted in a 4:1 mix of keratinocyte:
X-vivo media, respectively, and, thereby, in a drop of Ca++
in culture medium and subsequent silencing of numerous
Ca++-dependent genes.
The secretion of CXCL1 and CCL2 chemokines remained
either unaffected or was slightly decreased while that of
CXCL5 and CCL20 was increased upon co-culture with
CD8+T cells (Figures 1, 2). This is especially the case in
wild type and NFATc1-ko CD8+T cells. T cells from mice
double ko (DKO) for NFATc1 and NFATc2 remained “neutral”
with respect to CXCL1 and CCL20 secretion and enhanced
slightly the expression of CXCL5 when compared to wild
type and NFATc1-ko CD8+T cells (Figure 2). Since DKO
CD8+T cells are prone to apoptosis one may speculate that
pro-apoptotic signals emerged from those cells to increase
the secretion of pro-inflammatory chemokine CXCL5 (19)
by keratinocytes.
The secretion of CCL3 and CCL4 by CD8+T cells was strongly
suppressed upon co-culture with keratinocytes or upon culture
in SFM medium (Figure 3A). This silencing effect was also
reflected at the transcriptional level. The strong transcription of
Ccl3 and Ccl4 genes in pre-activated CD8+T cells was almost
abolished upon culture of T cells in SFM/X-vivo (4:1) medium,
without or with co-culture with keratinocytes whereas that of
the Ccl5 gene remained unaffected (Figure 3B). This is due to
the defect of NFAT activity in low Ca++ medium. In activated
cytotoxic T cells the promoters of Ccl3 and Ccl4 genes –
but not of the Ccl5 gene—are bound by NFATc1 (Figure 3C)
and, therefore, are excellent targets for NFATc1 in cytotoxic
T cells (16).
CXCL9 and CXCL10 Are Strongly Induced
in Keratinocytes by IFN-γ at the
Transcriptional Level
CXCL9 and CXCL10 were neither secreted by untreated
keratinocytes nor by activated WT CD8+T cells. However,
upon co-culture of keratinocytes with T cells pre-activated by
αCD3/CD28 for 1 d a massive induction of both chemokines
was observed. This was correlated with the NFAT expression of
T cells, since NFAT DKO CD8+T cells were unable to induce
any CXCL9 and CXCL10 secretion and NFATc2–ko CD8+T cells
showed a marked drop in the induction of both chemokines.
In contrast, in three out of five co-culture assays NFATc1-
ko cells did not show any restriction in chemokine induction
whereas in two assays a decrease was detected (Figures 4A,B
and Supplementary Figure 3A). A strong induction of CXCL9
and CXCL10 chemokines was also observed in keratinocytes
after culture for 1 d with “T cell-conditioned medium,” i.e.,
with X-VIVO medium in which CD8+T cells were activated
for 1 d by αCD3/CD28, whereas a poor induction was
observed using conditioned medium from NFAT DKO CD8+T
cells (Supplementary Figure 3B). The differences in chemokine
induction could be explained by marked differences in IFN-
γ secretion between NFAT DKO, NFATc1-ko, and NFATc2-ko
CD8+T cells. While DKO CD8+T cells did not synthesize any
IFN-γ, NFATc2-ko showed a strong, and NFATc1-ko cells a
more moderate decrease in IFN-γ secretion before and after
co-culture (Figures 4A,B). Along with the suppressive effect of
Abs directed against IFN-γ on CXCL9 and CXCL10 secretion
(Figure 1 and Supplementary Figure 2), these data indicate that
IFN-γ produced by CD8+T cells stimulates keratinocytes to
secrete CXCL9 and CXCL10.
NGS assays of the transcriptome of keratinocytes from WT
mice before and after co-culture with T cells for 1 d demonstrated
that the induction of CXCL9 and CXCL10 secretion occurs
at the transcriptional level. In cultured murine keratinocytes,
8440 genes were expressed in 5 and more RPKM, and 503
genes were changed 2.5 fold and more in their expression level
between keratinocytes without or upon co-culture with T cells.
When these 503 genes were analyzed using the GORILLA (gene
ontology enrichment analysis and visualization) tool, among
the most prominent 10 gene sets, 9 corresponded to genes
controlling response and defense mechanisms (Table 1). While
the top 2 pathways comprise genes induced in the interferon-
beta response, including the genes encoding the transcription
factors IRF1 and STAT1, the other pathways are characterized
by further response genes, including the Cxcl9 and Cxcl10 genes
(Supplementary Table 1). Upon co-culture for 1 d, the RNA
levels of the Cxcl9 gene increased more than 100 fold, and
that of the Cxcl10 gene approximately 10 fold (Figure 4C). A
2–5 fold increase was detected for the two genes encoding
STAT1 and STAT2. A similar increase was observed for the
Cd274 gene encoding PD1 ligand and the Tnf and Cd40lg genes
(Supplementary Figure 3C) that defend keratinocytes against T
cell-mediated killing.
It is worth mentioning that within the gene sets of the top 10
pathways induced in keratinocytes by T cells the overwhelming
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FIGURE 1 | Chemokine secretion of murine keratinocytes ex vivo. 105 keratinocytes cultured for 7 d in vitro were seeded in 12-well plates. They were cultivated alone
(columns 1–4 and 9–12) or together with 105 splenic CD4+ or CD8+T cells pre-activated for 1 d by αCD3/CD28 Abs (columns 5–8 and 13–16) for another day.
Keratinocytes remained unstimulated or were stimulated by IL-1α and/or TNF-α (30 ng/ml each), CsA (100 ng/ml), or IL-25 (2µg/ml) as indicated. In the assays 7 and
15, 5µg/ml of an Ab neutralizing IFN-γ was added. The supernatants of cultures were harvested and chemokine secretion was measured using a
fluorescence-encoded bead-based assay (BioLegend), *p < 0.05, **p < 0.005, ***p < 0.001.
majority of genes corresponded to genes induced by type I
interferons. In addition to the genes encoding the transcription
factors STAT1, STAT2, IRF1, IRF7 and IRF8, these include
the Casp1 and Gsdmd genes that code for caspase-1 and
gasdermin D—prominent inducers of pyroptosis and membrane
pore formation (21)—and numerous genes coding for guanylate
binding proteins, Tap transporters and proteasome subunits. All
these genes are compiled in the Supplementary Table 1.
Local CXCL10 Induction in Keratinocytes
From Lichen Planus Patients
Finally, we wanted to see whether our in vitro/ex vivo findings
on the interplay between murine CD8+T cells and keratinocytes
are of relevance for human skin disorders. To this end, we
selected lichen planus (LP) as model disease. LP is a T cell
mediated inflammatory disease that is characterized by the
massive infiltration of T lymphocytes, the destruction of the basal
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FIGURE 2 | Secretion of chemokines CXCL1, CXCL5 and CCL20 by keratinocytes alone or upon co-culture with CD8+T cells. Keratinocytes cultured for 7 d in vitro
and splenic CD8+ T cells pre-activated by αCD3/CD28 Ab for 1 d were either cultured alone or together in 6-well plates for 1 or 3 d as indicated and their chemokine
secretion measured.
epidermal layer and the induction of numerous genes with a
typical IFN signature (12, 13, 22). These include the chemokine
Cxcl9 and Cxcl10 genes as typical molecular LP markers that
distinguish lichenoid tissue reactions from atopic dermatitis and
psoriasis (12). In our co-stains of LP skin sections using Abs
directed against CXCL10, CD8, CD4, and pan-keratin (or Krt14)
we detected a strong expression of CXCL10 in keratinocytes
located mostly at the edge of elongated epidermal ridges closely
surrounded by infiltrating T cells. In contrast, infiltrating CD8+
and CD4+T cells showed rather a very weak staining with the
CXCL10 Ab (Figure 5 and Supplementary Figures 4, 5). For
quantification of CXCL10-expressing keratinocytes we counted
positive cells in each immunofluorescence stain of 10 patients and
compared results with healthy skin (Figure 5).
The immunofluorescence stains with two Abs directed against
CXCL9 did not show a distinct expression of CXCL9 in
keratinocyte at the keratinocyte/T cell border but a broad,
more diffuse expression in the invading cells, including CD4+T
lymphocytes and other cells (Figure 6).
The data on the role of NFAT factors in CXCL9 and
CXCL10 induction prompted us to speculate that in lichenoid
tissue reactions the nuclear expression of NFATs might be a
further molecular sign of infiltrating T cells. However, in all
immunofluorescence stains of such skin sections we were unable
to detect any clear-cut nuclear NFATc1 or NFATc2 localization
in infiltrating CD8+ and CD4+ T cells, but a prominent cytosolic
expression of bothNFAT factors (Supplementary Figures 6A,B).
DISCUSSION
The experimental data presented here extend a large body
of published results on the interplay between epidermal
keratinocytes and T lymphocytes (23, 24). Employing co-
culture experiments and analyzing supernatants (“conditioned
medium”) of activated CD8+T cells we demonstrated that T
lymphocytes modulate the chemokine synthesis of keratinocytes,
including the IFN-γ-mediated induction of CXCL9 and CXCL10
chemokines. In addition, we detected the induction of a large
set of type I IFN-inducible genes in keratinocytes. Similar
changes in gene expression have been described in the skin of
lichen planus patients (13) in which we detected the distinct
expression of CXCL10 in keratinocytes near the border to
invading T cells.
Compared to the situation in vivo, there are limitations of
our co-culture system. The infiltration of lymphocytes into
the skin and the attack of the stratum basale are a feature of
many skin diseases. In our co-cultures, keratinocytes of stratum
basale were exclusively propagated and studied. Therefore,
the attack of pre-activated T cells and the “liquefaction
degeneration” of the basal layer of the epidermis by cytotoxic
lymphocytes might reflect certain pathological situations
in vivo, such as in the skin of patients suffering from
lichen planus.
The massive changes in keratinocyte gene expression induced
by T cells suggest the existence of a fine-tuned balance between
keratinocytes and T lymphocytes that is disturbed in numerous
skin diseases. This might be due to metabolic changes in
primary keratinocytes which, like activated CD8+T cells (16),
exhibit a high glycolysis rate (own unpublished data). Our
data indicate that CXCL9 and CXCL10 are induced by IFN-γ
secreted by T cells. Both chemokines attract (autoreactive) T cells
expressing CXCR3, the common receptor for CXCL9, CXCL10
and CXCL11 (4), to the skin (25, 26). Albeit the co-culture
system does not reflect the complex cellular interplay between
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FIGURE 3 | Silencing of CCL3 and CCL4 secretion in keratinocyte medium. (A) Secretion of chemokines CCL3 and CCL4 by keratinocytes, CD8+T cells, or
co-cultures of both. Keratinocytes cultured for 7 d in vitro and splenic CD8+ T cells pre-activated by αCD3/CD28 Ab for 1 d were either cultured alone or together in
6-well plates for 1 or 3 d as indicated and their chemokine secretion was measured. (B) Suppression of Ccl3 and Ccl4, but not of Ccl5 transcription upon culture of
pre-activated CD8+T cells for 1 d in keratinocyte/X-vivo medium (4:1) alone (column 2) or in the presence of keratinocytes (column 3). Column 1 shows the RNA levels
of genes in pre-activated CD8+T cells cultured in X-vivo medium for 1 d. (C) Binding of NFATc1-bio protein to the promoters of murine Ccl3 and Ccl4 genes in
activated cytotoxic T cells. Results of ChIP seq assays (16). Splenic CD8+T cells from transgenic mice expressing NFATc1-bio proteins were stimulated by T+I for 5 h.
Their chromatin was cross-linked by 4% formaldehyde-treatment of cells in vitro, followed by shearing of chromatin and binding to streptavidin beads. After the
release of DNA from cross-linked chromatin complexes, DNA was sequenced in NGS assays (16, 20), *p < 0.05, **p < 0.005, ***p < 0.001.
keratinocytes, T cells, macrophages, dendritic cells, and others
in human skin diseases, it contributes to the understanding of T
cells/keratinocytes interactions. In LP patients, this “feed-back”
mechanism leads to a “flood” of invading T lymphocytes into
the dermis, the liquefaction degeneration of the basal epidermal
layer and the interference with keratinocyte differentiation (27).
Surprisingly, unlike CXCL10 we were unable to detect a distinct
expression of CXCL9 in keratinocytes of LP patients, in spite
of the comparable induction of CXCL9 and CXCL10 secretion
by murine keratinocytes upon co-culture with CD8+T cells.
However, a similar dichotomy in the expression of CXCL9 and
CXCL10 (and CXCL11) has been described before for different
human skin disorders. In those studies CXCL10 and CXCL11
were found to be predominantly expressed in basal keratinocytes
whereas CXCL9 expression was predominantly localized in
dermal infiltrates (15, 28).
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FIGURE 4 | Induction of CXCL9, CXCL10 and IFN-γ secretion in keratinocytes upon co-culture with CD8+T cells. (A,B) Secretion of chemokines CXCL9 and
CXCL10 and of IFN-γ by keratinocytes and CD8+T cells. Keratinocytes cultured for 7 d in vitro and splenic CD8+ T cells pre-activated by αCD3/CD28 Ab for 1 d
were either cultured alone or together in 6-well plates for another 1 or 3 d as indicated and their chemokine and IFN-γ secretion measured. In (A) the incubation of
NFAT-DKO T cells was included, in (B) the incubation of NFATc2-ko instead of DKO T cells. (C) Induction of Cxcl9 and Cxcl10 transcription in keratinocytes that were
cultured alone (column 1) or together with the same number of pre-activated CD8+ T cells for 1 d (column 2). In the co-culture, the CD8+ T cells were washed off,
and the RNA levels of keratinocytes were determined in NGS assays, *p < 0.05, **p < 0.005, ***p < 0.001.
It should be noted here that CXCR3 is not a skin-specific
chemokine receptor but attracts immune cells to sites of IFN-
γ-mediated inflammation (3). CXCR3 is not only expressed
on activated T cells but also on dendritic cells, natural killer
cells, fibroblasts, smooth muscle, and epithelial cells (25, 29).
Accordingly, the expression of CXCR3 and its activation by
chemokine ligands has been associated not only with numerous
skin diseases but also with other disorders, such as arthritis,
type 1 diabetes (30, 31), and allograft rejections including the
rejection of heterotopic heart allografts (32, 33). These findings
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FIGURE 5 | Enumeration of selectively accentuated CXCL10+ keratinocytes
in lichen planus patients. Representative immunofluorescence stainings for
CXCL10, CD8, and pan-cytokeratin (Pan-Kera) in (A) lichen planus (LP) and
(B) healthy skin (HS). Rectangle marks position of blow-up (right side).
(C) CXCL10+ cells were counted in at least 3 high power fields (HPF)/patient
(n = 10) and compared to HS. Confocal microscopy, 40x magnification.
underline the importance of CXCL9/CXCL10 signals in the
control of (auto-) immunity and have been exploited in immune
therapies against tumors (3, 34) in which CXCR3 is strongly
expressed (35, 36).
Apart from CXCL9 and CXCL10, the induction of genes
encoding caspase-1 and gasdermin D are additional steps in the
T cell-mediated “killing program” of keratinocytes. Caspase-1 is
an inflammatory response initiator that cleaves other proteins,
including the pyroptosis inducer gasdermin D (21). However,
keratinocytes are also able to fight back, as it is shown by the
induction of the Cd274 gene coding for the PD1 ligand, which—
through its binding to PD-1 on activated T cells—dampens T
cell activity (37, 38). Most of these genes are induced via type I
IFN pathways. This is demonstrated by the induction of Irf genes
Irf1, Irf7, and Irf8, and of Stat factors STAT1 and STAT2 that are
induced by type I IFNs (Supplementary Table 1).
The decrease in expression of Ccl3 and Ccl4 genes in pre-
activated CD8+T cells that we observed upon culture of T cells
in Ca++-poor SFM/X-vivo medium might be of relevance for
FIGURE 6 | Expression of CXCL9 in the skin of a lichen planus patient. Skin
sections were stained with Abs directed against CXCL9, NFATc1, and CD4
and co-stained with DAPI as indicated. Immunofluorescence microscopy, 40x
magnification.
the fate of T cells infiltrating the skin. In the basal layer of the
epidermis extracellular Ca++ concentrations are very low and
facilitate the proliferation of keratinocytes whereas increasing
Ca++ supports keratinocyte differentiation (39, 40). Therefore,
one may speculate that under physiological conditions invading
T cells that need Ca++ for full activity are inhibited. This is
reflected in the suppression of numerous Ca++-dependent genes
in our assays, including Ccl3, Ccl4, Ifn-γ , and further NFAT-
dependent genes.
The need for T cell activation and the inability of NFAT
DKO T cells to induce CXCL9 and CXCL10 indicate that the
IFN-γ-mediated induction of both chemokines is linked to
NFAT activity in T cells. In activated CD8+ T cells and, in
vivo, in cytotoxic T cells the synthesis of IFN-γ is under the
control of the NFAT factors NFATc1 and NFATc2. In CTLs,
inactivation of NFATc1 led to a complete loss of IFN-γ induction
upon TPA+ionomycin treatment whereas NFATc2 inactivation
exerted a milder defect, leading to a reduction of ∼60% (16).
Therefore, we expected to see a strong defect in CXCL9 and
CXCL10 induction by NFATc1-ko, but not NFATc2-ko T cells.
However, the opposite was observed. The strong decrease in IFN-
γ production by NFATc2-ko CD8+T cells suggests that under
the chosen experimental conditions, i.e., 1 day activation of
splenic CD8+T cells by αCD3/CD28 (followed by co-culture with
keratinocytes for 1 d), NFATc2—and not NFATc1—is the most
prominent NFAT factor to stimulate IFN-γ expression in murine
CD8+T cells. It remains to be shown whether this is also true for
skin-infiltating T cells in human skin diseases.
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